<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03378063</url>
  </required_header>
  <id_info>
    <org_study_id>stem cell for BPD</org_study_id>
    <nct_id>NCT03378063</nct_id>
  </id_info>
  <brief_title>Stem Cells for Bronchopulmonary Dysplasia</brief_title>
  <official_title>Stem Cells for Bronchopulmonary Dysplasia: a Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chongqing Maternal and Child Health Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Very preterm infants are at high risk to develop to bronchopulmonary dysplasia (BPD) for the&#xD;
      lack of effective measures to prevent or ameliorate this common and serious disorder. BPD&#xD;
      remains a major cause of mortality and lifelong morbidity in preterm infants&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several studies have shown that transplantation of mesenchymal stem cells (MSCs) in&#xD;
      immunocompetent animals attenuates lung injury, such as impaired alveolarization,&#xD;
      inflammatory response, increased apoptosis, and fibrosis. Human umbilical cord blood (hUCB)&#xD;
      is considered a better source of MSCs because of their ready availability and greater&#xD;
      proliferative capacity and less antigenicity than other cell types.&#xD;
&#xD;
      transplantation of hUCB-derived MSCs should be effective in treating BPD. The safety and&#xD;
      efficacy of MSC transplantation for prevention of BPD has not been tested previously,&#xD;
      however.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>death</measure>
    <time_frame>within two years</time_frame>
    <description>the infant is dead due to lung disease</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bayley Scales of Infant Development</measure>
    <time_frame>30 months after birth</time_frame>
    <description>scores of Bayley Scales of Infant Development at 2 months old and 2 years old</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Bronchopulmonary Dysplasia</condition>
  <arm_group>
    <arm_group_label>transplantation of mesenchymal stem cell</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>transplantation of mesenchymal stem cell will be given to the infants with BPD.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no transplantation of mesenchymal stem cell</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>transplantation of mesenchymal stem cell will be not given to the infants with BPD.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>transplantation of mesenchymal stem cell</intervention_name>
    <description>allogeneic human umbilical cord blood (hUCB)-derived mesenchymal stem cell (MSC) transplantation will be given to preterm infants</description>
    <arm_group_label>transplantation of mesenchymal stem cell</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>no transplantation of mesenchymal stem cell</intervention_name>
    <description>MSC transplantation will be not given to preterm infants</description>
    <arm_group_label>no transplantation of mesenchymal stem cell</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosed with BPD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  parents' rejection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Pediatrics, Daping Hospital, Research Institute of Surgery, Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400042</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Long Chen, MD</last_name>
      <phone>8613883559467</phone>
      <email>neuroclong@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Shi Yuan, PhD,MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>December 6, 2017</study_first_submitted>
  <study_first_submitted_qc>December 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2017</study_first_posted>
  <last_update_submitted>February 14, 2021</last_update_submitted>
  <last_update_submitted_qc>February 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</investigator_affiliation>
    <investigator_full_name>Chen Long,MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchopulmonary Dysplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

